Science News 2/6

MDMA & Psilocybin Use Linked To Lower Emotional Distress And Suicidality

Suicide is one of the leading causes of death in the world, and the United States has one of the highest suicide rates among the...

Psychedelics Permanently Alter Perception Of Consciousness

Psychedelic users have long reported experiencing profound shifts in how they perceive consciousness following a psychedelic experience....

fMRI Scans Show Psilocybin Promotes Brain Activity In Patients With Depression

As clinical trials and research into the use of psychedelics as therapeutic interventions for complex mental health conditions like...

Ketamine As A Potential Treatment For Parkinson’s Disease

A Canadian biotech company recently announced the results of their Phase 2 study that explored the viability of using ketamine as a...

MDMA-Assisted Therapy Significantly Reduces Eating Disorder Symptoms With PTSD

Eating Disorders (ED) and Post-Traumatic Stress Disorder (PTSD) are strongly correlated, however, no proven treatment options are...

Some Microdosers Are Successfully Reducing Psychiatric Medication Use

The world's largest annual drug survey, The Global Drug Survey (GDS) recently published the results of their 2021 survey which found that...

Study Shows Benefits Of Psilocybin Treatment for Major Depression Last One Year

John Hopkins University researchers have published the results of a follow-up study of patients with major depressive disorder (MDD) who...

Linguistic Analysis Of Different Psychedelic Drug Experiences

A group of researchers recently analyzed reports of psychedelic experiences from five different substances to better understand the...

First-Ever DMT-Assisted Psychotherapy Trial Establishes Safety

The viability of psychedelic compounds as a treatment option for a variety of mental health disorders has been gaining steady momentum...

New Study Strongly Supports Ketamine Therapy For Alcohol Use Disorder

A recent phase II double-blind placebo-controlled study conducted by Awakn Life Sciences, a Canadian biotech company focused on solutions...

Can Psychedelics Treat Dementia?

Dementia is a debilitating neurodegenerative disease impacting 1 in 7 Americans over the age of 70 with many more struggling with...

New Research Establishes Safety And Feasibility For Group Psilocybin Administration

A recent phase 1, randomized, double-blind, placebo-controlled study conducted by the Institute of Psychiatry, Psychology, & Neuroscience...

Mindful Microdosing Course

A 6-Week Self-Guided Journey To Build, Evolve & Deepen Your Mindful Microdosing Practice

Designed for POSITIVE & LASTING CHANGE